StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IVVD

Invivyd, Inc.

IVVD Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$0.55
+0.02 +3.18%

Key statistics

from XBRL data in SEC filings
Market cap
$163M
Revenue (TTM)
$55.9M
Net income (TTM)
-$77.6M
EPS (TTM)
$-0.29
P/E ratio
Dividend yield
Free cash flow
-$58.3M
Cash
$184M
Total assets
$242M
Gross margin
52-week range
$0.48 – $3.07

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Delisting notice or listing-rule failure Jul 24, 2026 8-K Other events Jul 6, 2026 8-K Shareholder vote results May 19, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Other events May 14, 2026 8-K Other events Apr 9, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release); Other events Mar 5, 2026 8-K Results of operations (earnings release); Other events Jan 8, 2026 8-K Other events Dec 23, 2025 8-K Other events Nov 24, 2025 8-K Entered a material agreement; Other events Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Other events Nov 6, 2025 8-K Other events Oct 30, 2025 8-K Other events Oct 6, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Sep 24, 2025 8-K Entered a material agreement; Other events Aug 22, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Other events Aug 14, 2025 8-K Other events Jul 2, 2025 8-K Other events Jun 26, 2025 8-K Shareholder vote results May 20, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Other events May 15, 2025 8-K Other events May 12, 2025 8-K Delisting notice or listing-rule failure Apr 25, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Apr 21, 2025 8-K Director or officer change; Regulation FD disclosure Mar 26, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Other events Mar 5, 2025 8-K Other events Feb 24, 2025 8-K Results of operations (earnings release); Other events Feb 3, 2025 8-K Other events Jan 27, 2025 8-K Other events Jan 10, 2025 8-K Delisting notice or listing-rule failure Dec 27, 2024 8-K Director or officer change Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release); Other events Nov 14, 2024